Peifen Fu

2.4k total citations
54 papers, 1.6k citations indexed

About

Peifen Fu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Peifen Fu has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 29 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Peifen Fu's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (10 papers) and Breast Cancer Treatment Studies (10 papers). Peifen Fu is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (10 papers) and Breast Cancer Treatment Studies (10 papers). Peifen Fu collaborates with scholars based in China, United States and Japan. Peifen Fu's co-authors include Weiyang Lou, Minya Yao, Bisha Ding, Kezhen Lv, Chengyong Du, Haiyan Wei, Yaomin Chen, Feiya Du, Yu Liu and Bajin Wei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Peifen Fu

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peifen Fu China 24 1.1k 856 428 185 158 54 1.6k
Xiaoyan Xu China 23 1.3k 1.2× 487 0.6× 433 1.0× 225 1.2× 198 1.3× 79 1.8k
Wei Jin China 23 1.0k 1.0× 523 0.6× 577 1.3× 182 1.0× 262 1.7× 72 1.7k
Ce Li China 24 1.1k 1.1× 758 0.9× 624 1.5× 310 1.7× 201 1.3× 70 1.7k
Cailu Song China 23 1.3k 1.2× 968 1.1× 483 1.1× 155 0.8× 253 1.6× 36 1.8k
Xiao‐En Xu China 20 815 0.8× 647 0.8× 354 0.8× 117 0.6× 187 1.2× 28 1.3k
Giulia Bottai Italy 17 1.2k 1.2× 902 1.1× 588 1.4× 230 1.2× 299 1.9× 27 1.9k
Xinbao Hao China 14 1.3k 1.2× 835 1.0× 506 1.2× 123 0.7× 117 0.7× 35 1.8k
Lin Guo China 21 731 0.7× 440 0.5× 332 0.8× 138 0.7× 180 1.1× 71 1.3k

Countries citing papers authored by Peifen Fu

Since Specialization
Citations

This map shows the geographic impact of Peifen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peifen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peifen Fu more than expected).

Fields of papers citing papers by Peifen Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peifen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peifen Fu. The network helps show where Peifen Fu may publish in the future.

Co-authorship network of co-authors of Peifen Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Peifen Fu. A scholar is included among the top collaborators of Peifen Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peifen Fu. Peifen Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Peifen, et al.. (2025). The Role of Extracellular Vesicles in Musculoskeletal Diseases. Journal of Extracellular Vesicles. 14(11). e70205–e70205.
2.
Fu, Peifen, Yan Luo, Zhengyong Ren, et al.. (2025). Prg4 and Osteoarthritis: Functions, Regulatory Factors, and Treatment Strategies. Biomedicines. 13(3). 693–693. 1 indexed citations
3.
Yang, Jun, Keda Yang, Peifen Fu, et al.. (2025). Harnessing nanochaperone-triggered ferritinophagy for targeted protein degradation and breast cancer therapy. Chemical Engineering Journal. 525. 169802–169802.
4.
Guo, Jiabao, et al.. (2022). Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer. Frontiers in Oncology. 12. 1026647–1026647. 6 indexed citations
5.
Yao, Minya, Shuqian Wang, Luyan Chen, Bajin Wei, & Peifen Fu. (2021). Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer. Clinical and Experimental Medicine. 22(2). 201–207. 11 indexed citations
7.
Wu, Minjie, Peifen Fu, Lei Qu, Jian Liu, & Aifu Lin. (2020). Long Noncoding RNAs, New Critical Regulators in Cancer Immunity. Frontiers in Oncology. 10. 550987–550987. 42 indexed citations
8.
Lou, Weiyang, Bisha Ding, & Peifen Fu. (2020). Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Frontiers in Cell and Developmental Biology. 8. 85–85. 114 indexed citations
9.
Zhu, Haiying, Chengyong Du, Meng Yuan, et al.. (2020). PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer. Drug Discovery Today. 25(9). 1762–1771. 26 indexed citations
10.
Lou, Weiyang, et al.. (2020). Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma. Frontiers in Oncology. 10. 576615–576615. 11 indexed citations
11.
Fu, Peifen, Xin Zheng, Fan Xiao, & Aifu Lin. (2019). Role of cytoplasmic lncRNAs in regulating cancer signaling pathways. Journal of Zhejiang University SCIENCE B. 20(1). 1–8. 38 indexed citations
12.
Xiong, Yan, Peifen Fu, Lei Qu, et al.. (2019). Exosomal long non-coding RNAs: biological properties and therapeutic potential in cancer treatment. Journal of Zhejiang University SCIENCE B. 20(6). 488–495. 14 indexed citations
13.
Zhang, Zhengkui, Shuai Wang, Li Shao, et al.. (2018). OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Molecular Cell. 73(1). 7–21.e7. 141 indexed citations
14.
Shen, Jiaying, Chengyong Du, Danni Chen, et al.. (2017). A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. Cell Death and Differentiation. 25(2). 406–420. 78 indexed citations
15.
Shen, Jiaying, Jie Pan, Chengyong Du, et al.. (2017). Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer. Cell Death and Disease. 8(4). e2740–e2740. 73 indexed citations
16.
Wei, Haiyan, Peifen Fu, Minya Yao, Yaomin Chen, & Linlin Du. (2016). Breast cancer stem cells phenotype and plasma cell-predominant breast cancer independently indicate poor survival. Pathology - Research and Practice. 212(4). 294–301. 20 indexed citations
17.
Wang, Linbo, Chao Yuan, Kezhen Lv, et al.. (2013). Lin28 Mediates Radiation Resistance of Breast Cancer Cells via Regulation of Caspase, H2A.X and Let-7 Signaling. PLoS ONE. 8(6). e67373–e67373. 38 indexed citations
19.
Fu, Peifen, Mutsuko Ibusuki, Yutaka Yamamoto, et al.. (2011). Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer. Breast Cancer. 19(4). 321–328. 9 indexed citations
20.
Ibusuki, Mutsuko, Peifen Fu, Satoko Yamamoto, et al.. (2011). Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens. Breast Cancer. 20(2). 159–166. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026